Loading
Paper cited by one bottleneck page and twelve idea pages, indexed on Europe PMC as PubMed record 18548043 and published in Nature; the citing pages link this DOI, which is how the record was matched.
Europe PMC indexes no abstract for this record; the title is the only text available.
Indexed on Europe PMC as PubMed record 18548043 (DOI 10.1038/453840a). Matched by DOI alone: one bottleneck page and twelve idea pages cite this DOI among their external links (the pages are listed under Related), and this page was written so that the citation resolves inside OnCo. No figure has been checked by an editor.
One bottleneck page and twelve idea pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Shares Two-year translational fellowships that pay scientists to develop their own discovery, A national non-profit contract research organisation for academic oncology trials, A global first-in-human network for academic cancer trials with single ethics review, Hospital-exemption cell therapies at scale, backed by a shared registry.
Shares A diversified royalty pool that finances academic phase 1 trials across fifty assets, A phase 0 fund to test academic compounds in humans with microdoses and imaging, The valley of death between lab and product.
Shares Hospital-funded protected time for clinician-scientists, repaid by trial revenue, Two-year translational fellowships that pay scientists to develop their own discovery.
Shares A phase 0 fund to test academic compounds in humans with microdoses and imaging, The valley of death between lab and product.
Shares A diversified royalty pool that finances academic phase 1 trials across fifty assets, The valley of death between lab and product.
Shares A diversified royalty pool that finances academic phase 1 trials across fifty assets, The valley of death between lab and product.
Shares A national non-profit contract research organisation for academic oncology trials, The valley of death between lab and product.
Shares A translation fund for academic surgical devices and radiotherapy technology, The valley of death between lab and product.